loader
Please Wait
Applying Filters...

Market Place

Market Place

Market Place

Menu

Post Enquiry

Post Enquiry

PharmaCompass

Home

Market Place

Market Place

Search
All
API
FDF
Price
Services
Excipients
Enquiries

    Find

    • Active Pharmaceutical Ingredients Active Pharmaceutical Ingredients
    • Finished Drug Formulations Finished Drug Formulations
    • Price Price
    • Excipients Excipients
    • Services Services
    • Market Place Marketplace

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    Consultant-Needed-Insert
    X

    A clinical trial helps to find a method to treat disease, it’s the only way to test investigational medications. With the strict oversight by Institutional Review Boards, clinical trials provide the U.S. Food and Drug Administration with the scientific information needed to weigh the benefits and risks of a new medication and decide whether it is safe for patients. Early phase, or phase I and phase II study are the first step in testing new medicines that have been developed in the lab. Phase 1 clinical research, usually focuses on ensuring the safety of drugs to use in population rather than how effective it may be as a treatment for a given disease. For selecting the clinical Phase 1 units for large normal, healthy volunteer studies, Sponsors and CROs usually make their selections by determining whether or not a site fulfills a set of standard criteria, which will ultimately determine if the site is equipped to conduct the study at all. To shorten the development timeline of complex molecules, many biopharmaceutical companies are moving toward hybrid, early clinical development (ECD) study models, which require both healthy volunteers and patient populations. Phase 0 trials are the first clinical trials done among people. They aim to learn how a drug is processed in the body and how it affects the body. In these trials, a very small dose of a drug is given to about 10 to 15 people. Clinical trials involving new drugs are commonly classified into four phases. Individual trials may encompass more than one phase. A common example of this is combined phase I/II or phase II/III trials. Therefore, it may be easier to think of early phase studies and late phase studies.[1] The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases I, II, and III, it will usually be approved by the national regulatory authority for use in the general population. Phase IV are 'post-approval' studies. Phase IIa clinical study evaluate the efficacy and safety in a selected population of patients with the disease or condition to be treated, diagnosed, or prevented. Objectives are focused on dose-response, type of patient, frequency of dosing, or numerous other characteristics of safety and efficacy. Phase IIb trials are well controlled trials to evaluate efficacy and safety in the population with the disease or condition to be treated, diagnosed, or prevented. These clinical trials usually represent the most rigorous demonstration of a medicine's efficacy. Sometimes referred to as pivotal trials. The phases of clinical research are the steps in which scientists do experiments with a health intervention in an attempt to find enough evidence for a process which would be useful as a medical treatment. In the case of pharmaceutical study, the phases start with drug design and drug discovery then proceed on to animal testing. If this is successful, they begin the clinical phase of development by testing for safety in a few human subjects and expand to test in many study participants to determine if the treatment is effective. The purpose of early stage clinical trials is to determine the recommended dose and toxicity profile of an investigational agent or multi?drug combination. Molecularly targeted agents (MTAs) and immunotherapies have distinct toxicities from chemotherapies that are often not dose dependent and can lead to chronic and sometimes unpredictable side effects. Therefore utilizing a dose escalation method that has toxicity based endpoints may not be as appropriate for determination of recommended dose, and alternative parameters such as pharmacokinetic or pharmacodynamic outcomes are potentially appealing options. The Early Phase Clinical Trials Team (EPCTT) has around 20 ongoing studies and accepts several new patient referrals each week. Please see the Early phase clinical research page for details of current early phase trials in the Cambridge area.

    capsugel-m-Default-Wallpaper
    capsugel-m-Default-Wallpaper
    Previous
    Next
    Filters Filter
    ×
    FILTER DATA :

    filter

    Azidus Laboratories

    BLUEPHARMA - INDUSTRIA FARMACEUTICA, S.A

    Celerion

    Chiltern International Ltd

    ICBio Clinical Research Pvt Ltd

    MPI Research Inc

    Nutrasource

    Nuvisan GmbH

    PAREXEL International Corporation

    Pharmaceutical Product Development, LLC

    Quotient Sciences

    filter

    CANADA

    GERMANY

    INDIA

    PORTUGAL

    UNITED KINGDOM

    UNITED STATES

    Quotient Sciences

    • FDA
    • EDQM

    Virtual BoothTransforming Drug Development with Science & Innovation.

    UNITED KINGDOM United Kingdom

    Contact Supplier Contact Supplier

    Virtual Booth Virtual Booth

    6th Formulation & Drug Delivery

    Attending

    Request a Meeting Now

    Phase 1 Clinical Pharmacology Study

    Supporting Information: Click here to upload a PDF
    Link Icon Link to Supplier Content
    Contact the Supplier

    - Service Details

    Quotient has the experience & expertise to seamlessly deliver your studies with the highest quality service & speed to clinical data. If you need a complete service including data management, analysis, statistics, medical writing, Quotient is your answer.

    - Directory Listing

    Pharma Service: Clinical Trials

    Category: Early Clinical / Phase I-IIa

    Sub Category: Phase I / IIa

    Chiltern International Ltd

      Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

      UNITED KINGDOM United Kingdom

      Contact Supplier Post An Enquiry

      Virtual Booth Virtual Booth

      AFSSI Connexions 2020

      Participation Not Confirmed

      Update your events

      Clinical Development Services & Solutions

      Supporting Information: Click here to upload a PDF
      Link Icon Link to Supplier Content
      Contact the Supplier

      - Service Details

      Chiltern provides the following services for Phase llb - III Late-stage programs: Protocol feasibility and design, CRF development, Recruitment, Data management, Medical writing, Biostatistics, Drug safety monitoring committees

      - Directory Listing

      Pharma Service: Clinical Trials

      Category: Early Clinical / Phase I-IIa

      Sub Category: Phase I / IIa

      Pharmaceutical Product Development, LLC

      • FDA

      Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

      UNITED STATES United States

      Contact Supplier Post An Enquiry

      Virtual Booth Virtual Booth

      AFSSI Connexions 2020

      Participation Not Confirmed

      Update your events

      Early Development Clinical Research Services

      Supporting Information: Click here to upload a PDF
      Link Icon Link to Supplier Content
      Contact the Supplier

      - Service Details

      Program services offered by both clinics range from medical writing, clinical conduct and data management to monitoring, biostatistics and clinical pharmacology.

      - Directory Listing

      Pharma Service: Clinical Trials

      Category: Early Clinical / Phase I-IIa

      Sub Category: Phase I / IIa

      MPI Research Inc

        Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

        UNITED STATES United States

        Contact Supplier Post An Enquiry

        Virtual Booth Virtual Booth

        AFSSI Connexions 2020

        Participation Not Confirmed

        Update your events

        Supporting Drug Development at Phase III

        Supporting Information: Click here to upload a PDF
        Link Icon Link to Supplier Content
        Contact the Supplier

        - Service Details

        MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

        - Directory Listing

        Pharma Service: Clinical Trials

        Category: Early Clinical / Phase I-IIa

        Sub Category: Phase I / IIa

        MPI Research Inc

          Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

          UNITED STATES United States

          Contact Supplier Post An Enquiry

          Virtual Booth Virtual Booth

          AFSSI Connexions 2020

          Participation Not Confirmed

          Update your events

          Supporting Drug Development at Phase I & II

          Supporting Information: Click here to upload a PDF
          Link Icon Link to Supplier Content
          Contact the Supplier

          - Service Details

          MPI Research is a full early-stage drug development CRO that partners with biopharmaceutical, biotechnology, medical device, animal health, and chemical industries to advance global healthcare. MPI Research supports all phases of the drug development pathway, ranging from target identification

          - Directory Listing

          Pharma Service: Clinical Trials

          Category: Early Clinical / Phase I-IIa

          Sub Category: Phase I / IIa

          Celerion

          • FDA

          Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

          UNITED STATES United States

          Contact Supplier Post An Enquiry

          Virtual Booth Virtual Booth

          AFSSI Connexions 2020

          Participation Not Confirmed

          Update your events

          Global CRO- Phase I & ll Studies

          Supporting Information: Click here to upload a PDF
          Link Icon Link to Supplier Content
          Contact the Supplier

          - Service Details

          With over 40 years of experience, more than 600 beds in North America and Europe, Celerion offers the largest global Phase I and II clinical operations networks in the industry.

          - Directory Listing

          Pharma Service: Clinical Trials

          Category: Early Clinical / Phase I-IIa

          Sub Category: Phase I / IIa

          PAREXEL International Corporation

          • FDA

          Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

          UNITED STATES United States

          Contact Supplier Post An Enquiry

          Virtual Booth Virtual Booth

          AFSSI Connexions 2020

          Participation Not Confirmed

          Update your events

          Bioequivalence Studies

          Supporting Information: Click here to upload a PDF
          Link Icon Link to Supplier Content
          Contact the Supplier

          - Service Details

          With more than 40 years of experience in performing bioequivalence studies, our clinical unit in Bloemfontein, South Africa, is a center of excellence. It is strategically placed in the perfect location for these trials a lower cost and fast start-up environment.

          - Directory Listing

          Pharma Service: Clinical Trials

          Category: Early Clinical / Phase I-IIa

          Sub Category: Phase I / IIa

          Nutrasource

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            CANADA Canada

            Contact Supplier Post An Enquiry

            Virtual Booth Virtual Booth

            AFSSI Connexions 2020

            Participation Not Confirmed

            Update your events

            Early Phase Clinical Trials

            Supporting Information: Click here to upload a PDF
            Link Icon Link to Supplier Content
            Contact the Supplier

            - Service Details

            We have a speciality in early phase trials involving healthy volunteers. Early phase trials may have many factors that must be considered to achieve the research goals.

            - Directory Listing

            Pharma Service: Clinical Trials

            Category: Early Clinical / Phase I-IIa

            Sub Category: Phase I / IIa

            Pharmaceutical Product Development, LLC

            • FDA

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            UNITED STATES United States

            Contact Supplier Post An Enquiry

            Virtual Booth Virtual Booth

            AFSSI Connexions 2020

            Participation Not Confirmed

            Update your events

            Phase I Clinic Capabilities

            Supporting Information: Click here to upload a PDF
            Link Icon Link to Supplier Content
            Contact the Supplier

            - Service Details

            PPD’s Phase I clinic conducts approximately 100 studies per year and has sufficient capacity to carry out multiple studies of varying design simultaneously. Research-experienced, board-certified physicians serve as principal investigators for Phase I studies. Secure and confidential drug

            - Directory Listing

            Pharma Service: Clinical Trials

            Category: Early Clinical / Phase I-IIa

            Sub Category: Phase I / IIa

            PAREXEL International Corporation

            • FDA

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            UNITED STATES United States

            Contact Supplier Post An Enquiry

            Virtual Booth Virtual Booth

            AFSSI Connexions 2020

            Participation Not Confirmed

            Update your events

            Phase 1 Clinical Trials

            Supporting Information: Click here to upload a PDF
            Link Icon Link to Supplier Content
            Contact the Supplier

            - Service Details

            PAREXEL® has the global SOPs to perform Phase 1 clinical trials in harmony across multiple locations, and stands committed to the success of your journey.

            - Directory Listing

            Pharma Service: Clinical Trials

            Category: Early Clinical / Phase I-IIa

            Sub Category: Phase I / IIa

            PAREXEL International Corporation

            • FDA

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            UNITED STATES United States

            Contact Supplier Post An Enquiry

            Virtual Booth Virtual Booth

            AFSSI Connexions 2020

            Participation Not Confirmed

            Update your events

            Phase lla

            Supporting Information: Click here to upload a PDF
            Link Icon Link to Supplier Content
            Contact the Supplier

            - Service Details

            PAREXEL® has developed an integrated and adaptive approach that supports Phase IIa outcomes.

            - Directory Listing

            Pharma Service: Clinical Trials

            Category: Early Clinical / Phase I-IIa

            Sub Category: Phase I / IIa

            Nutrasource

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              CANADA Canada

              Contact Supplier Post An Enquiry

              Virtual Booth Virtual Booth

              AFSSI Connexions 2020

              Participation Not Confirmed

              Update your events

              Study Start-Up

              Supporting Information: Click here to upload a PDF
              Link Icon Link to Supplier Content
              Contact the Supplier

              - Service Details

              Our team understands that upfront planning is critical for the success of every clinical trial and that planning must be produced in cooperation with your clinical team.

              - Directory Listing

              Pharma Service: Clinical Trials

              Category: Early Clinical / Phase I-IIa

              Sub Category: Phase I / IIa

              Nuvisan GmbH

              • FDA

              Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

              GERMANY Germany

              Contact Supplier Post An Enquiry

              Virtual Booth Virtual Booth

              AFSSI Connexions 2020

              Participation Not Confirmed

              Update your events

              Clinical Development Services

              Supporting Information: Click here to upload a PDF
              Link Icon Link to Supplier Content
              Contact the Supplier

              - Service Details

              Nuvisan Clinical Development offers various clinical services including Studies with biologicals, Drug/Drug interaction studies, Food effect studies, Bioavailability & Bioequivalence Studies, Phase IIa, Proof of Concept studies special patient populations

              - Directory Listing

              Pharma Service: Clinical Trials

              Category: Early Clinical / Phase I-IIa

              Sub Category: Phase I / IIa

              Azidus Laboratories

                Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

                INDIA India

                Contact Supplier Post An Enquiry

                Virtual Booth Virtual Booth

                AFSSI Connexions 2020

                Participation Not Confirmed

                Update your events

                Phase I Studies

                Supporting Information: Click here to upload a PDF
                Link Icon Link to Supplier Content
                Contact the Supplier

                - Service Details

                Azidus has experienced team of professionals to handle the all phases of drug development from Phase I to Phase IV clinical trials. The technical team can design & execute the phase trials at committed time as per the International regulatory guidelines.

                - Directory Listing

                Pharma Service: Clinical Trials

                Category: Early Clinical / Phase I-IIa

                Sub Category: Phase I / IIa

                ICBio Clinical Research Pvt Ltd

                • Audit Compliance

                Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

                INDIA India

                Contact Supplier Post An Enquiry

                Virtual Booth Virtual Booth

                AFSSI Connexions 2020

                Participation Not Confirmed

                Update your events

                Phase 1 Clinical Pharmacology Study

                Supporting Information: Click here to upload a PDF
                Link Icon Link to Supplier Content
                Contact the Supplier

                - Service Details

                We have capabilities to conduct Phase I Studies on Healthy Volunteers & offers Phase I studies for NCEs & NBEs. We also offer services on clinical pharmacology studies including Food Effect, Drug Interaction studies, PK/PD studies, studies for biomarkers.

                - Directory Listing

                Pharma Service: Clinical Trials

                Category: Early Clinical / Phase I-IIa

                Sub Category: Phase I / IIa

                BLUEPHARMA - INDUSTRIA FARMACEUTICA, S.A

                • FDA
                • EDQM

                Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

                PORTUGAL Portugal

                Contact Supplier Post An Enquiry

                Virtual Booth Virtual Booth

                AFSSI Connexions 2020

                Participation Not Confirmed

                Update your events

                Phase I Studies

                Link Icon Document
                Contact the Supplier

                - Service Details

                Bluepharma performs its activity from product development to the end of the value chain, that is, finished product supply.

                - Directory Listing

                Pharma Service: Clinical Trials

                Category: Early Clinical / Phase I-IIa

                Sub Category: Phase I / IIa

                A clinical trial helps to find a method to treat disease, it’s the only way to test investigational medications. With the strict oversight by Institutional Review Boards, clinical trials provide the U.S. Food and Drug Administration with the scientific information needed to weigh the benefits and risks of a new medication and decide whether it is safe for patients. Early phase, or phase I and phase II study are the first step in testing new medicines that have been developed in the lab. Phase 1 clinical research, usually focuses on ensuring the safety of drugs to use in population rather than how effective it may be as a treatment for a given disease. For selecting the clinical Phase 1 units for large normal, healthy volunteer studies, Sponsors and CROs usually make their selections by determining whether or not a site fulfills a set of standard criteria, which will ultimately determine if the site is equipped to conduct the study at all. To shorten the development timeline of complex molecules, many biopharmaceutical companies are moving toward hybrid, early clinical development (ECD) study models, which require both healthy volunteers and patient populations. Phase 0 trials are the first clinical trials done among people. They aim to learn how a drug is processed in the body and how it affects the body. In these trials, a very small dose of a drug is given to about 10 to 15 people. Clinical trials involving new drugs are commonly classified into four phases. Individual trials may encompass more than one phase. A common example of this is combined phase I/II or phase II/III trials. Therefore, it may be easier to think of early phase studies and late phase studies.[1] The drug-development process will normally proceed through all four phases over many years. If the drug successfully passes through Phases I, II, and III, it will usually be approved by the national regulatory authority for use in the general population. Phase IV are 'post-approval' studies. Phase IIa clinical study evaluate the efficacy and safety in a selected population of patients with the disease or condition to be treated, diagnosed, or prevented. Objectives are focused on dose-response, type of patient, frequency of dosing, or numerous other characteristics of safety and efficacy. Phase IIb trials are well controlled trials to evaluate efficacy and safety in the population with the disease or condition to be treated, diagnosed, or prevented. These clinical trials usually represent the most rigorous demonstration of a medicine's efficacy. Sometimes referred to as pivotal trials. The phases of clinical research are the steps in which scientists do experiments with a health intervention in an attempt to find enough evidence for a process which would be useful as a medical treatment. In the case of pharmaceutical study, the phases start with drug design and drug discovery then proceed on to animal testing. If this is successful, they begin the clinical phase of development by testing for safety in a few human subjects and expand to test in many study participants to determine if the treatment is effective. The purpose of early stage clinical trials is to determine the recommended dose and toxicity profile of an investigational agent or multi?drug combination. Molecularly targeted agents (MTAs) and immunotherapies have distinct toxicities from chemotherapies that are often not dose dependent and can lead to chronic and sometimes unpredictable side effects. Therefore utilizing a dose escalation method that has toxicity based endpoints may not be as appropriate for determination of recommended dose, and alternative parameters such as pharmacokinetic or pharmacodynamic outcomes are potentially appealing options. The Early Phase Clinical Trials Team (EPCTT) has around 20 ongoing studies and accepts several new patient referrals each week. Please see the Early phase clinical research page for details of current early phase trials in the Cambridge area.

                ABOUT
                THE PAGE

                COLLAPSE

                PharmaCompass >>

                First
                Previous
                Next
                Last

                Market Place

                Market Place

                PharmaCompass

                Home

                Market Place

                Menu

                Post Enquiry

                Post Enquiry

                Market Place

                Market Place

                Search